Company dynamics
In H1 2026, Kingdomway's revenue rose whilst net profit fell, declining by more than 30% YoY.
In H1 2026, Tianxin Pharma's net profit declined by 10.31% YoY, whilst the price of vitamin B6 fell to a historic low.
On 25 August, 2026, Zhejiang Medicine released its 2026 interim report.
On 1 September, 2026, Nestlé announced that it had reached an agreement with Yellow Wood Partners LLC to sell its mass-market vitamins, minerals and supplements business.
Project progress
On 8 September, 2026, the EI report for Brother Vitamin's 422 t/a acetamidine hydrochloride upgrading project was announced to be approved.
On 8 September, 2026, the EI report for Brother Pharma's vitamin B3 and ancillary products construction project was proposed to be accepted and publicised.
On 18 September, 2026, Chaoqun Hechuang published a patent for a water-soluble feed additive containing a 25-hydroxyvitamin D3 inclusion complex.
On 18 September, 2026, the EI report for Brother Pharma's vitamin and catalytic materials technical renovation project was announced to be approved.
The USD/RMB exchange rate in this Report is USD1.00=CNY6.7809 on 1 September, 2026, sourced from the People's Bank of China. All the prices mentioned in this report will include the VAT, unless otherwise specified.
Please purchase to view
Add to cart
